MedTrace Logo

Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in Taiwan

NCT03283956 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-09-15

No results posted yet for this study

Summary

To evaluate efficacy and safety profile of DC bead® TACE in patients with hepatocellular carcinoma in Taiwan.

Conditions

  • Hepatocellular Carcinoma Non-resectable
  • Chemoembolization, Therapeutic

Interventions

DEVICE

Patient records

Retrospective analysis of medical records of all patients who underwent DC Bead TACE at National Taiwan University Hospital, National Cheng Kung University Hospital, and Taichung Veterans General Hospital from 2010-2017/7

Sponsors & Collaborators

  • National Cheng-Kung University Hospital

    collaborator OTHER

  • Taichung Veterans General Hospital

    collaborator OTHER

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chien-Hung Chen, MD · National Taiwan University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-13
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03283956 on ClinicalTrials.gov